This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ohtsuki, K. Articles by Strauss, H. W. Search for Related Content PubMed PubMed Citation Articles by Ohtsuki, K. Articles by Strauss, H. W. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Cardiovascular imaging agents/Techniques

(Circulation. 2001;104:203.)
© 2001 American Heart Association, Inc.

Basic Science Reports

Detection of Monocyte Chemoattractant Protein-1 Receptor Expression in Experimental Atherosclerotic Lesions

An Autoradiographic Study

Katsuichi Ohtsuki, MD; Motoya Hayase, MD; Koichi Akashi, MD; Susan Kopiwoda, MS; H. William Strauss, MD

From the Division of Nuclear Medicine, Department of Radiology (K.O., S.K., H.W.S.), the Division of Cardiovascular Medicine, Department of Medicine (M.H.), and the Departments of Pathology and Developmental Medicine (K.A.), Stanford University School of Medicine, Stanford, Calif.

Correspondence to H. William Strauss, MD, Division of Nuclear Medicine, Stanford University Medical Center, Room H-0101, 300 Pasteur Dr, Stanford, CA 94305. billstra{at}leland.stanford.edu

Background—— Monocytes, a common component of atheroma, are attracted to the lesion site in response to chemotactic signals, particularly expression of monocyte chemoattractant peptide 1 (MCP-1). This study assessed the feasibility of using radiolabeled MCP-1 to identify monocytes and macrophages that have localized at sites of experimental arterial lesions.

Methods and Results—— The biodistribution of radiolabeled MCP-1 was determined in normal mice, and localization in experimental atheroma was determined in cholesterol-fed rabbits 4 weeks after arterial injury of the iliac artery (9 rabbits) and the abdominal aorta (1 rabbit). Vessels were harvested and autoradiographed after intravenous administration of ¹²⁵I-labeled MCP-1 and Evans blue dye. The arteries were evaluated histologically by hematoxylin and eosin staining and immune staining with a monoclonal antibody specific for rabbit macrophages (RAM-11). ¹²⁵I-MCP-1 has a blood clearance half-time of 10 minutes and circulates in association with cells. The liver, lungs, and kidneys had the highest concentration of ¹²⁵I-MCP-1 at 5 and 30 minutes after tracer administration. Autoradiograms revealed accumulation of ¹²⁵I-MCP-1 in the damaged artery wall, with an average ratio of lesion to normal vessel of 6:1 (maximum 45:1). The accumulation of ¹²⁵I-MCP-1 in the reendothelialized (plaque formation) areas was greater than in the deendothelialized (Evans blue-positive) areas (6.55±2.26 versus 4.34±1.43 counts/pixel, P<0.05). The uptake of ¹²⁵I-MCP-1 correlated with the number of macrophages per unit area (r=0.85, P<0.0001).

Conclusions—— Radiolabeled MCP-1 may be a useful tracer for imaging monocyte/macrophage-rich experimental atherosclerotic lesions.

Key Words: monocyte chemoattractant proteins • atherosclerosis • macrophages • autoradiography

This article has been cited by other articles:

				H. F. Langer, R. Haubner, B. J. Pichler, and M. Gawaz Radionuclide imaging a molecular key to the atherosclerotic plaque. J. Am. Coll. Cardiol., July 1, 2008; 52(1): 1 - 12. [Abstract] [Full Text] [PDF]

				M. R. Vesely and V. Dilsizian Nuclear Cardiac Stress Testing in the Era of Molecular Medicine J. Nucl. Med., March 1, 2008; 49(3): 399 - 413. [Abstract] [Full Text] [PDF]

				M. P. S. Dunphy, H. Schoder, and H. W. Strauss Radionuclide Techniques for Identifying Vulnerable Plaque J. Nucl. Med., November 1, 2007; 48(11): 1753 - 1755. [Full Text] [PDF]

				D. Hartung, A. Petrov, N. Haider, S. Fujimoto, F. Blankenberg, A. Fujimoto, R. Virmani, F. D. Kolodgie, H. W. Strauss, and J. Narula Radiolabeled Monocyte Chemotactic Protein 1 for the Detection of Inflammation in Experimental Atherosclerosis J. Nucl. Med., November 1, 2007; 48(11): 1816 - 1821. [Abstract] [Full Text] [PDF]

				J. C. Wu, F. M. Bengel, and S. S. Gambhir Cardiovascular Molecular Imaging Radiology, August 1, 2007; 244(2): 337 - 355. [Abstract] [Full Text] [PDF]

				S. Musaad and E. N. Haynes Biomarkers of Obesity and Subsequent Cardiovascular Events Epidemiol. Rev., May 10, 2007; (2007) mxm005v1. [Abstract] [Full Text] [PDF]

				M. C. Cid, M. P. Hoffman, J. Hernandez-Rodriguez, M. Segarra, M. Elkin, M. Sanchez, C. Vilardell, A. Garcia-Martinez, M. Pla-Campo, J. M. Grau, et al. Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritis Rheumatology, November 1, 2006; 45(11): 1356 - 1363. [Abstract] [Full Text] [PDF]

				K. Nasu, E. Tsuchikane, O. Katoh, D. G. Vince, R. Virmani, J.-F. Surmely, A. Murata, Y. Takeda, T. Ito, M. Ehara, et al. Accuracy of In Vivo Coronary Plaque Morphology Assessment: A Validation Study of In Vivo Virtual Histology Compared With In Vitro Histopathology J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2405 - 2412. [Abstract] [Full Text] [PDF]

				J. R. Davies, J. H.F. Rudd, P. L. Weissberg, and J. Narula Radionuclide imaging for the detection of inflammation in vulnerable plaques. J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C57 - C68. [Abstract] [Full Text] [PDF]

				H. W. Strauss, C. Mari, B. E. Patt, and V. Ghazarossian Intravascular radiation detectors for the detection of vulnerable atheroma. J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C97 - C100. [Abstract] [Full Text] [PDF]

				C. M. Matter, M. T. Wyss, P. Meier, N. Spath, T. von Lukowicz, C. Lohmann, B. Weber, A. R. de Molina, J. C. Lacal, S. M. Ametamey, et al. 18F-Choline Images Murine Atherosclerotic Plaques Ex Vivo Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 584 - 589. [Abstract] [Full Text] [PDF]

				A. Schober, A. Zernecke, E. A. Liehn, P. von Hundelshausen, S. Knarren, W. A. Kuziel, and C. Weber Crucial Role of the CCL2/CCR2 Axis in Neointimal Hyperplasia After Arterial Injury in Hyperlipidemic Mice Involves Early Monocyte Recruitment and CCL2 Presentation on Platelets Circ. Res., November 26, 2004; 95(11): 1125 - 1133. [Abstract] [Full Text] [PDF]

				Y.-M. Chen, W.-C. Chiang, S.-L. Lin, K.-D. Wu, T.-J. Tsai, and B.-S. Hsieh Dual Regulation of Tumor Necrosis Factor-{alpha}-Induced CCL2/Monocyte Chemoattractant Protein-1 Expression in Vascular Smooth Muscle Cells by Nuclear Factor-{kappa}B and Activator Protein-1: Modulation by Type III Phosphodiesterase Inhibition J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 978 - 986. [Abstract] [Full Text] [PDF]

				B. D. MacNeill, H. C. Lowe, M. Takano, V. Fuster, and I.-K. Jang Intravascular Modalities for Detection of Vulnerable Plaque: Current Status Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1333 - 1342. [Abstract] [Full Text] [PDF]

				A. R. Silva, E. F. de Assis, L. F. C. Caiado, G. K. Marathe, M. T. Bozza, T. M. McIntyre, G. A. Zimmerman, S. M. Prescott, P. T. Bozza, and H. C. Castro-Faria-Neto Monocyte Chemoattractant Protein-1 and 5-Lipoxygenase Products Recruit Leukocytes in Response to Platelet-Activating Factor-Like Lipids in Oxidized Low-Density Lipoprotein J. Immunol., April 15, 2002; 168(8): 4112 - 4120. [Abstract] [Full Text] [PDF]